Dena Akram Jerjees Ahmad
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
Ahmad, Dena Akram Jerjees; Negm, Ola H.; Layth Alabdullah, M.; Mirza, Sameer; Hamed, Mohamed R.; Band, Vimla; Green, Andrew R.; Ellis, Ian O.; Rakha, Emad
Authors
Dr Ola Negm ola.negm@nottingham.ac.uk
ASSISTANT PROFESSOR
M. Layth Alabdullah
Sameer Mirza
Mohamed R. Hamed
Vimla Band
Dr Andy Green ANDREW.GREEN@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Ian O. Ellis
Professor EMAD RAKHA Emad.Rakha@nottingham.ac.uk
PROFESSOR OF BREAST CANCER PATHOLOGY
Abstract
Background Mitogen-activated protein kinases (MAPKs) are signalling transduction molecules that have different functions and diverse behaviour in cancer. In breast cancer, MAPK is related to oestrogen receptor (ER) and HER2.
Methods Protein expression of a large panel of MAPKs (JNK1/2, ERK, p38, C-JUN and ATF2 including phosphorylated forms) were assessed immunohistochemically in a large (n = 1400) and well-characterised breast cancer series prepared as tissue microarray. Moreover, reverse phase protein array was applied to quantify protein expression of MAPKs in six breast cancer cell lines with different phenotypes including HER2-transfected cells.
Results MAPKs expression was associated with clinicopathological variables characteristic of good prognosis. These associations were most significant in the whole series and in the ER? subgroup compared to other BC classes. Most of MAPKs showed a positive association with ER, BCL2 and better outcome and were negatively associated with the proliferation marker Ki67 and p53. Association of MAPK with HER2 was mainly seen in the ER- subgroup. Reverse phase protein array confirmed immunohistochemistry results and revealed differential expression of MAPK proteins in ER? and ER- cell lines.
Conclusions MAPKs are associated with good prognosis and their expression is mainly related to ER. Studying a large panel rather than individual biomarkers may provide improved understanding of the pathway
Citation
Ahmad, D. A. J., Negm, O. H., Layth Alabdullah, M., Mirza, S., Hamed, M. R., Band, V., Green, A. R., Ellis, I. O., & Rakha, E. (2016). Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers. Breast Cancer Research and Treatment, 159(3), 457-467. https://doi.org/10.1007/s10549-016-3967-9
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 26, 2016 |
Online Publication Date | Sep 3, 2016 |
Publication Date | 2016-10 |
Deposit Date | Sep 26, 2016 |
Publicly Available Date | Sep 26, 2016 |
Journal | Breast Cancer Research and Treatment |
Print ISSN | 0167-6806 |
Electronic ISSN | 1573-7217 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 159 |
Issue | 3 |
Pages | 457-467 |
DOI | https://doi.org/10.1007/s10549-016-3967-9 |
Keywords | MAPK signalling pathways; reverse phase protein microarray (RPPA); breast cancer |
Public URL | https://nottingham-repository.worktribe.com/output/819297 |
Publisher URL | http://link.springer.com/article/10.1007%2Fs10549-016-3967-9 |
Contract Date | Sep 26, 2016 |
Files
art%3A10.1007%2Fs10549-016-3967-9 - Springer.pdf
(969 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
The role of the ALKBH5 RNA demethylase in invasive breast cancer
(2024)
Journal Article
Epitranscriptomic mechanisms of androgen signalling and prostate cancer
(2024)
Journal Article
Stromal lymphocytes are associated with upgrade of B3 breast lesions
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search